Logo image of EAST

EASTSIDE DISTILLING INC (EAST) Stock Fundamental Analysis

USA - NASDAQ:EAST - US2778024016 - Common Stock

0.8867 USD
+0.01 (+0.88%)
Last: 1/24/2025, 8:00:01 PM
0.8503 USD
-0.04 (-4.11%)
After Hours: 1/24/2025, 8:00:01 PM
Fundamental Rating

1

Overall EAST gets a fundamental rating of 1 out of 10. We evaluated EAST against 32 industry peers in the Beverages industry. EAST has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EAST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EAST had negative earnings in the past year.
EAST had a negative operating cash flow in the past year.
EAST had negative earnings in each of the past 5 years.
In the past 5 years EAST always reported negative operating cash flow.
EAST Yearly Net Income VS EBIT VS OCF VS FCFEAST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -47.82%, EAST is doing worse than 93.10% of the companies in the same industry.
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROIC N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EAST Yearly ROA, ROE, ROICEAST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

EAST has a Gross Margin of 8.90%. This is amonst the worse of the industry: EAST underperforms 93.10% of its industry peers.
In the last couple of years the Gross Margin of EAST has declined.
The Profit Margin and Operating Margin are not available for EAST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%
EAST Yearly Profit, Operating, Gross MarginsEAST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

EAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAST has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EAST has more shares outstanding
Compared to 1 year ago, EAST has an improved debt to assets ratio.
EAST Yearly Shares OutstandingEAST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
EAST Yearly Total Debt VS Total AssetsEAST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

EAST has an Altman-Z score of -8.77. This is a bad value and indicates that EAST is not financially healthy and even has some risk of bankruptcy.
EAST's Altman-Z score of -8.77 is on the low side compared to the rest of the industry. EAST is outperformed by 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.77
ROIC/WACCN/A
WACC6.07%
EAST Yearly LT Debt VS Equity VS FCFEAST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.29 indicates that EAST may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.29, EAST is doing worse than 89.66% of the companies in the same industry.
A Quick Ratio of 0.18 indicates that EAST may have some problems paying its short term obligations.
With a Quick ratio value of 0.18, EAST is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.18
EAST Yearly Current Assets VS Current LiabilitesEAST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.90% over the past year.
EAST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -40.85%.
The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%

3.2 Future

EAST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.51% yearly.
Based on estimates for the next years, EAST will show a very strong growth in Revenue. The Revenue will grow by 30.21% on average per year.
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EAST Yearly Revenue VS EstimatesEAST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
EAST Yearly EPS VS EstimatesEAST Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EAST. In the last year negative earnings were reported.
Also next year EAST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EAST Price Earnings VS Forward Price EarningsEAST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EAST Per share dataEAST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

EAST's earnings are expected to grow with 26.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.94%
EPS Next 3Y26.51%

More info and screens

0

5. Dividend

5.1 Amount

EAST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EASTSIDE DISTILLING INC

NASDAQ:EAST (1/24/2025, 8:00:01 PM)

After market: 0.8503 -0.04 (-4.11%)

0.8867

+0.01 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners9.75%
Inst Owner Change-66.57%
Ins Owners5.01%
Ins Owner Change0%
Market Cap4.16M
Analysts82.86
Price Target3.57 (302.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.54%
Min EPS beat(2)-4.02%
Max EPS beat(2)39.1%
EPS beat(4)1
Avg EPS beat(4)-65.98%
Min EPS beat(4)-247.59%
Max EPS beat(4)39.1%
EPS beat(8)3
Avg EPS beat(8)-64.89%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-31.7%
Min Revenue beat(2)-75.73%
Max Revenue beat(2)12.33%
Revenue beat(4)1
Avg Revenue beat(4)-40.8%
Min Revenue beat(4)-75.73%
Max Revenue beat(4)12.33%
Revenue beat(8)1
Avg Revenue beat(8)-37.64%
Revenue beat(12)3
Avg Revenue beat(12)-23.56%
Revenue beat(16)3
Avg Revenue beat(16)-23.95%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.45
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS1.36
BVpS-0.52
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.9%
FCFM N/A
ROA(3y)-44.62%
ROA(5y)-42.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.87%
GM growth 5Y-23.17%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.18
Altman-Z -8.77
F-Score3
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)66.85%
Cap/Depr(5y)70.3%
Cap/Sales(3y)7.35%
Cap/Sales(5y)8.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.75%
EPS Next Y56.38%
EPS Next 2Y34.94%
EPS Next 3Y26.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-40.85%
Revenue growth 3Y-9.17%
Revenue growth 5Y11.4%
Sales Q2Q%-74.52%
Revenue Next Year-0.77%
Revenue Next 2Y31.2%
Revenue Next 3Y30.21%
Revenue Next 5YN/A
EBIT growth 1Y22.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.9%
EBIT Next 3Y46.83%
EBIT Next 5YN/A
FCF growth 1Y69.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.7%
OCF growth 3YN/A
OCF growth 5YN/A